ArticleBlood2013

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.

Christopher J Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.